Legal CBD in Switzerland and France: What’s Different (and Why It Matters)

By Don99 (Dante Kane) — Master Hashmaker, Hash Gang, St-Légier, Vaud (CH)

CBD is legal in Switzerland. CBD is legal in France. So far, so simple.

But “legal” doesn’t mean the same thing on both sides of the border. The permitted THC level is not the same. The regulatory framework for new psychoactive substances is not the same. And the consequences for you, the consumer, are not the same.

The following is a factual overview—free of judgment or bias—to provide a concrete understanding of what distinguishes the two frameworks. And why this affects the quality and safety of the products you buy.

---

The Swiss Legal Framework at a Glance

In Switzerland, CBD is regulated by two main pieces of legislation:

The Narcotics Act (LStup) defines illicit cannabis as cannabis with a THC content exceeding 1%. As a direct result, a Swiss CBD product may legally contain up to 1% total THC, compared to 0.3% in France and the EU.

The Food Act (LDA) regulates CBD products marketed as food or wellness products (capsules, herbal teas, resins for oral consumption). It imposes traceability, labeling, and compliance requirements that many market players do not fully comply with.

The 1% THC threshold is often misunderstood: it does not mean that Swiss products are “stronger” or “less legal.” It reflects a difference in legislative classification. A product with 0.8% THC is legal in Switzerland but illegal in France. A product with 0.2% THC is legal in both countries.

---

New Psychoactive Substances: A Swiss Law That Offers Greater Protection

This is the least well-known aspect—and yet the most important one for understanding why the Swiss CBD market is structurally better regulated than the French market.

Since 2016, Switzerland has had a specific law: the LNPS (Federal Act on New Psychoactive Substances). Its principle is simple yet powerful: it allows authorities to quickly add a new psychoactive substance to a list of controlled substances, even before it is classified as a narcotic in the traditional sense.

What this means in practice:
When a new synthetic compound appears on the market (HHC, H4CBD, THCP…), France must go through a process to classify it as a narcotic—a lengthy procedure with delays that leave months or even years of legal limbo. Meanwhile, the substance is sold freely.

In Switzerland, the LNPS allows for action to be taken within this timeframe. This is why HHC, for example, is subject to restrictions in Switzerland, whereas the formal ban in France was not finalized until mid-2023—after several months of unrestricted sales.

It’s not a matter of moral integrity. It’s a matter of legal tools. Switzerland has developed a system for rapid adaptation. France has a more rigid framework that reacts more slowly to market innovations. Switzerland’s LNPS allows for the rapid regulation of new psychoactive substances. To learn more about HHC specifically, check out our article on the differences between HHC and CBD.

---

What this means in practical terms for consumers

Appearance	Switzerland	France
Maximum Legal THC Level	1 %	0,3 %
Framework for New Substances	LNPS (reactive, rapid)	Classification of Narcotics (slow)
HHC Status	LNPS-Certified	Banned since June 2023
H4CBD Status	LNPS-Certified	Gray area currently under review
Traceability Requirement	LDA (General Traceability)	General Product Regulations
Online Sales	Authorized (CBD < 1% THC)	Authorized (CBD < 0.3% THC)
Import for Personal Use	THC content < 1%	Tolerance < 0.3% THC
COA required by law	No (voluntary practice)	No (voluntary practice)

Switzerland’s LNPS allows for the faster regulation of new psychoactive substances; in France, classification as a narcotic typically takes several months on average.

---

Cross-Border Delivery Between Switzerland and France: What You Need to Know

This is an area where the same questions come up regularly—and where the answers depend on which side of the border you’re on.

From Switzerland to France:
A package containing legal Swiss CBD resin (

Confusion Over Thresholds:
Many consumers believe that a product that is “legal in Switzerland” is automatically “legal throughout Europe.” This is not the case. The applicable legal framework is that of the destination country, not the country of origin. A product containing 0.8% THC is legal in Switzerland but illegal upon entry into France. This distinction is crucial for anyone ordering from abroad or traveling with CBD products.

---

---

FAQ — Legal CBD in Switzerland vs. France

What is the main legal difference between Swiss CBD and French CBD?

The legal THC threshold is 1% in Switzerland, compared to 0.3% in France and the EU. In addition, Switzerland has the LNPS—a specific law on new psychoactive substances that regulates emerging cannabinoids more quickly than the French classification system.

Is a Swiss CBD product legal in France?

Not automatically. Legality depends on the THC content: if a Swiss CBD product contains between 0.3% and 1% THC, it is legal in Switzerland but illegal to import into France. Only products with a THC content of less than 0.3% comply with both sets of regulations.

Does the Swiss LNPS apply to CBD?

The LNPS (Federal Act on New Psychoactive Substances) does not apply to CBD itself, which is legal. It applies to new psychoactive substances such as HHC, H4CBD, or THCP—semisynthetic cannabinoids that may be mixed into CBD products without being clearly labeled.

Can you order Swiss CBD from France?

Yes, provided that the product complies with the 0.3% THC limit in effect in France. Products that comply with both legal frameworks can be legally ordered and delivered. Always check the COA before purchasing to confirm compliance with French regulations.

Is the legal framework for CBD likely to change in Switzerland or France?

In France, discussions on European harmonization are continuing within the framework of the EFSA’s Novel Food Regulation. In Switzerland, the LNPS framework is regularly updated. Both countries are following developments in European recommendations, but the timelines and implementation procedures differ. Staying informed through official sources (FOPH for Switzerland, ANSM for France) remains best practice.